Tuberculosis (TB) remains a major health problem worldwide. The infectious agent,
Mycobacterium tuberculosis, has a unique ability to survive within the host, alternating …

Mycobacterium tuberculosis (M. tb) is an intracellular pathogen that predominantly affects
the alveolar macrophages in the respiratory tract. Upon infection, the activation of TLR2 and …

Tuberculosis (TB) still continues to be a major killer disease worldwide. Unlike other bacteria
Mycobacterium tuberculosis (Mtb) has the ability to become dormant within the host and to …

Latent tuberculosis infection (LTBI) represents a major challenge to curing TB disease.
Current guidelines for LTBI management include only three older drugs and their …

Tuberculosis is still a global health burden. It is caused by Mycobacterium tuberculosis
which afflicts around one third of the world's population and costs around 1.3 million people …

Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is a tenacious
pathogen that has latently infected one third of the world's population. However …

MTB lysine-ɛ-aminotransferase (LAT) was found to play a crucial role in persistence and
antibiotic tolerance. LAT serves as a potential target in the management of latent …

Despite being discovered and isolated more than one hundred years ago, tuberculosis (TB)
remains a global public health concern arch. Our inability to eradicate this bacillus is …

One-third of the world's population harbours the latent tuberculosis infection (LTBI) with a
lifetime risk of reactivation. Although, the treatment of LTBI relies significantly on the first-line …

Tuberculosis (TB) is a global health issue. Millions of TB-infected patients remain
undiagnosed, untreated, or improperly treated, leading to recurrence, re-infection, and …